CI

At a glance

ClinicalIndex Comparison Record
Phase 4Completed· 2 enrolled
Drug / intervention
Tissue sealantdrug
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT02952365
NCT02952365Phase 4Completed
CompareCT.gov

A Prospective Evaluation of Tissue Sealant to Prevent Epithelial Ingrowth in Repeat LASIK Surgery

Stanford University·interventional·Posted Nov 2, 2016·Updated Dec 14, 2021

In Brief

A Phase 4 clinical trial evaluating Tissue sealant for Epithelial Ingrowth. Completed, enrolled 2 participants across 1 site.

Detailed Summary

The purpose of the study is to evaluate the use of prophylactic tissue sealant to prevent epithelial ingrowth from gaining access under a LASIK flap with repeat LASIK surgery

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsEpithelial Ingrowth
CountriesUnited States
Collaborators--

Timeline

Phase 4CompletedFinished
2017201820192020202120222023202420252026
First PostedNov 2, 2016
Enrollment StartOct 1, 2016
Primary CompletionMay 22, 2017
TodayJul 2, 2026
Enrollment to primary: 8 monthsPosted 9.7 years ago

Interventions

Tissue sealantdrug

Application of tissue sealant on eyes undergoing LASIK enhancement